SCHEMBL5665281

SCHEMBL5665281

O=C(O)c1ccccc1Oc1ccccc1NS(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 13/20 0.70
CCR1 P32246 2/20 0.70
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
CYP1A2 P05177 2/20 0.61
CYP3A4 P08684 2/20 0.61
CYP2D6 P10635 2/20 0.61
CYP2C9 P11712 2/20 0.61
CYP2C19 P33261 2/20 0.61
CCR4 P51679 2/20 0.61
CCR5 P51681 2/20 0.61
KCNH2 Q12809 1/20 0.61
ALDH1A1 P00352 1/20 0.55
KDM4E B2RXH2 1/20 0.53
POLB P06746 1/20 0.53
SLC16A3 O15427 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5670223 0.86 CCR2 (0.77) CCR2CCR1MEN1KMT2ACYP1A2
SCHEMBL7348029 0.86 MEN1 (0.70) MEN1KMT2AALDH1A1KDM4EPOLB
Diphenylmethanol SCHEMBL8077142 0.81 CCR2 (0.68) CCR2CCR1MEN1KMT2ACYP1A2
SCHEMBL5666146 0.79 CCR2 (0.67) CCR2CCR1MEN1KMT2ACYP1A2
SCHEMBL3563444 0.78 SLC16A3 (0.74) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL1035847 0.78 MEN1 (1.00) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL7188482 0.77 SLC16A3 (0.54) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL18151726 0.77 KMT2A (0.67) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL7208212 0.77 ALDH1A1 (0.63) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL3554736 0.76 SLC16A3 (0.68) MEN1KMT2AALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799198-B1 ANTI-INFLAMMATORY COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2000-08-30 EP claimed
EP-0799198-A4 1997-10-15 EP claimed
EP-0799198-A1 ANTI-INFLAMMATORY COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1997-10-08 EP claimed
WO-1995033461-A1 ANTI-INFLAMMATORY COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-12-14 WO claimed
EP-0904069-A4 PLA2 INHIBITORS OF ANGIOGENESIS SMITHKLINE BEECHAM CORP (US) 2006-08-23 EP disclosed
EP-0799198-B1 ANTI-INFLAMMATORY COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2000-08-30 EP disclosed
EP-0904069-A1 PLA2 INHIBITORS OF ANGIOGENESIS SMITHKLINE BEECHAM CORPORATION (US) 1999-03-31 EP disclosed
EP-0799198-A4 1997-10-15 EP disclosed
EP-0799198-A1 ANTI-INFLAMMATORY COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1997-10-08 EP disclosed
WO-1997035567-A1 PLA2 INHIBITORS OF ANGIOGENESIS SMITHKLINE BEECHAM CORPORATION (US) 1997-10-02 WO disclosed
US-5545669-A Anti-inflammatory compounds SMITHKLINE BEECHAM CORPORATION 1996-08-13 US disclosed
WO-1995033461-A1 ANTI-INFLAMMATORY COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-12-14 WO disclosed